Best practice portal main page
Contingency management for improving adherence to antiretroviral therapy
Summary of the evidence
Contingency management (CM) interventions for people with HIV and substance use disorder were found in a systematic review with meta-analysis (Ribeiro et al. 2023, five studies) to have a more positive effect when compared to control conditions in:
- adherence to antiretroviral therapy during the intervention period (improved patient adherence by 2.69 (95% confidence interval: [0.08, 0.51]; p = .007)).
Adherence to antiretroviral therapy was measured by counting the increase in CD4 (a type of white blood cell).
Details
Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.
